#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adrenoleukodystrophy Glycogen storage disease type I Oesophageal atresia Anti-HLA antibody test positive Ocular myasthenia Retinopathy proliferative Haemophilia B without inhibitors Ornithine transcarbamoylase deficiency Philadelphia positive acute lymphocytic leukaemia Pemphigus Osteosarcoma Bone marrow disorder Mycobacterium abscessus infection Cholangiocarcinoma Stevens-Johnson syndrome More trials…

    Learn about Rare Diseases

    Medulloblastoma – Diagnostics Hyperoxaluria – Trials in Disease Tuberous sclerosis complex – Treatment Alexander disease Ehlers-Danlos syndrome – Life with Disease Propionic acidaemia – Treatment Malignant fibrous histiocytoma – Basic Information Waldenstrom’s macroglobulinaemia recurrent – Life with Disease Alexander disease – Diagnostics Fabry’s disease – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Linperlisib Xp-Dc+Tl+Klh Etoposide Phosphate Siponimod Fumaric Acid Human Plasma Protein Cat Epithelia Leflunomide TRIMIPRAMINE MALEATE Glibenclamide Emibetuzumab PUCOTENLIMAB Lifileucel Resiniferatoxin Masofaniten Casirivimab Emactuzumab Gadobutrol Chloride Ion Nebivolol S095035 More therapies…

    Learn about Your Condition

    Pulmonary fibrosis Cardiomyopathy Frostbite Bacterial vaginosis Menopause Perineal injury Organ donor Wolfram syndrome Ligament sprain Nephrotic syndrome Juvenile absence epilepsy Endometriosis Postprandial hypoglycaemia End stage renal disease Myotonic dystrophy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Region Oestergoetland

Region Oestergoetland

Universitetssjukhuset I Linkoping, Linkoping, 581 85, Sweden

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness of Biomarker Staging Compared to Conventional Staging in Women with Early-Stage Endometrial Cancer Using Paclitaxel and Carboplatin

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Carboplatin
    • Paclitaxel
    Sweden

  • Study on the Safety and Effects of AZD4831 for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) with Fibrosis

    Not recruiting

    2 1
    Investigated Drugs:
    • Azd4831
    Denmark Italy Norway Portugal Spain Sweden

  • Study of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Anhydrous Cyclophosphamide
    • Carboplatin
    • Filgrastim
    France Germany Ireland Italy Poland Portugal +2

  • Study on Imlifidase and Drug Combination for Treating Severe Goodpasture Disease in Patients

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Cyclophosphamide
    • Imlifidase
    • Loratadine
    Austria Belgium Czechia Denmark France Germany +6

  • Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Loperamide
    • Loperamide Hydrochloride
    • Navtemadlin
    Austria Czechia Denmark Estonia Finland France +9

  • Study of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Anhydrous Docetaxel
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia Denmark Finland France +7

  • Study on Dexamethasone Eye Drops for Infants with Retinopathy of Prematurity

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Retinopathy proliferative
    Investigated Drugs:
    • Dexamethasone Phosphate
    Sweden

  • Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Atrial fibrillation
    • Thrombosis prophylaxis
    Investigated Drugs:
    • Apixaban
    • Asundexian
    Austria Belgium Bulgaria Czechia Denmark Estonia +16
Previous Page
1 2

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!